Etk/Bmx Regulates Proteinase-Activated-Receptor1 (PAR₁) in Breast Cancer Invasion: Signaling Partners, Hierarchy and Physiological Significance

• Irit Cohen,

  Affiliation Department of Oncology, Hadassah-University Hospital, Jerusalem, Israel

  ⨯
• Myriam Maoz,

  Affiliation Department of Oncology, Hadassah-University Hospital, Jerusalem, Israel

  ⨯
• Hagit Turm,

  Affiliation Department of Oncology, Hadassah-University Hospital, Jerusalem, Israel

  ⨯
• Sorina Grisaru-Granovsky,

  Affiliation Department of Oncology, Hadassah-University Hospital, Jerusalem, Israel

  ⨯
• Bella Maly,

  Affiliation Department of Pathology, Hadassah-University Hospital, Jerusalem, Israel

  ⨯
• Beatrice Uziely,

  Affiliation Department of Oncology, Hadassah-University Hospital, Jerusalem, Israel

  ⨯
• Einat Weiss,

  Affiliation Department of Oncology, Hadassah-University Hospital, Jerusalem, Israel

  ⨯
• Rinat Abramovitch,

  Affiliation Goldyne Savad Institute for Gene Therapy, Hadassah-University Hospital, Jerusalem, Israel

  ⨯
• Eithan Gross,

  Affiliation Department of Pediatric Surgery, Hadassah-University Hospital, Jerusalem, Israel

  ⨯
• Oded Barzilay,

  Affiliation Department of Oncology, Hadassah-University Hospital, Jerusalem, Israel

  ⨯
• Yun Qiu,

  Affiliation Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Rachel Bar-Shavit

  * E-mail: rachel.bar-shavit@ekmd.huji.ac.il

  Affiliation Department of Oncology, Hadassah-University Hospital, Jerusalem, Israel

  ⨯